Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell membrane cholesterol and lipid microdomains, commonly referred to as lipid rafts, are specialized, dynamic regions of the plasma membrane enriched in cholesterol, sphingolipids, and specific proteins (Pike, 2006). These microdomains function as organized platforms that compartmentalize cellular processes, particularly signal transduction, membrane trafficking, and the assembly of viral particles (Simons & Toomre, 2000). By concentrating signaling molecules such as G protein-coupled receptors and tyrosine kinases, lipid rafts facilitate efficient communication between the extracellular environment and the cell interior. In various diseases, these domains are hijacked; for instance, many viruses, including HIV-1 and SARS-CoV-2, utilize lipid rafts for entry and budding (Lu et al., 2008). In cancer, they often harbor overactive growth factor receptors that drive tumor progression and provide resistance to apoptosis. Therapeutic strategies targeting these microdomains often involve the use of cholesterol-depleting agents or alkylphospholipids to disrupt raft integrity and inhibit pathological signaling (Mollinedo et al., 2010). However, because these structures are fundamental to normal cell physiology, achieving selectivity remains a significant challenge in drug development.
Drugs targeting these microdomains typically act by depleting or sequestering membrane cholesterol, which leads to the structural disintegration of the rafts and the subsequent displacement or inactivation of raft-resident signaling proteins and receptors (Simons & Toomre, 2000). Some agents, such as edelfosine, selectively accumulate in rafts to trigger pro-apoptotic signaling cascades (Mollinedo et al., 2010).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membrane cholesterol and lipid microdomains (Lipid rafts) (Lipid rafts).